Long-COVID is rapidly becoming one of the most common chronic diseases worldwide. However, the pathogenic mechanisms underlying the development of this new disease are still largely poorly understood. Recent evidence suggests that pre-existing inflammatory lung diseases may increase the risk of developing long-COVID, including chronic fatigue.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- From symptom to diagnosis
Lung carcinoma – Pancoast tumor
- From symptom to diagnosis
Abdominal pain – Intraductal papillary mucinous neoplasia
- IBDmatters - Advanced Therapeutic Treatments
Examinations and considerations before therapy
- Journal Club
Management of axial spondyloarthritis
- Multiple myeloma
DREAMM-7: Belamaf plus bortezomib and dexamethasone outperforms comparator therapy
- COPD
Better outcomes through patient education and integrated care
- Atopic dermatitis and allergies Atopic dermatitis and allergies
Type 2 inflammation and other factors
- Case Report